{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:26:28Z","timestamp":1792499188960,"version":"4.5.0"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1001\/jamaneurol.2019.0242","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T11:01:01Z","timestamp":1552302061000},"page":"701","source":"Crossref","is-referenced-by-count":94,"title":["Fractures and Linear Growth in a Nationwide Cohort of Boys With Duchenne Muscular Dystrophy With and Without Glucocorticoid Treatment"],"prefix":"10.1001","volume":"76","author":[{"given":"Shuko","family":"Joseph","sequence":"first","affiliation":[{"name":"Developmental Endocrinology Research Group, Royal Hospital for Children, Glasgow, Scotland"},{"name":"Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunyi","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Mathematics and Statistics, University of Glasgow, Glasgow, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Bushby","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Institute of Human Genetics, Newcastle University, Newcastle Upon Tyne, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Guglieri","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Institute of Human Genetics, Newcastle University, Newcastle Upon Tyne, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Horrocks","sequence":"additional","affiliation":[{"name":"Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Straub","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Institute of Human Genetics, Newcastle University, Newcastle Upon Tyne, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Faisal","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Developmental Endocrinology Research Group, Royal Hospital for Children, Glasgow, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze Choong","family":"Wong","sequence":"additional","affiliation":[{"name":"Developmental Endocrinology Research Group, Royal Hospital for Children, Glasgow, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the UK NorthStar Clinical Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"noi190007r1","first-page":"CD003725","article-title":"Corticosteroids for the treatment of Duchenne muscular dystrophy.","volume":"1","author":"Matthews","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"noi190007r2","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1177\/0883073810371004","article-title":"Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management.","volume":"25","author":"Moxley","year":"2010","journal-title":"J Child Neurol"},{"issue":"2","key":"noi190007r3","first-page":"121","article-title":"Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients.","volume":"31","author":"Passamano","year":"2012","journal-title":"Acta Myol"},{"issue":"1","key":"noi190007r4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"issue":"1","key":"noi190007r5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40360-016-0111-8","article-title":"Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids.","volume":"18","author":"Parente","year":"2017","journal-title":"BMC Pharmacol Toxicol"},{"key":"noi190007r6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jpeds.2016.02.067","article-title":"Corticosteroid treatment and growth patterns in ambulatory males with Duchenne muscular dystrophy.","volume":"173","author":"Lamb","year":"2016","journal-title":"J Pediatr"},{"issue":"12","key":"noi190007r7","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1212\/WNL.0000000000001950","article-title":"Prednisone\/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study.","volume":"85","author":"Bello","year":"2015","journal-title":"Neurology"},{"issue":"10","key":"noi190007r8","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1469-8749.2002.tb00272.x","article-title":"Fracture prevalence in Duchenne muscular dystrophy.","volume":"44","author":"McDonald","year":"2002","journal-title":"Dev Med Child Neurol"},{"issue":"4","key":"noi190007r9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1177\/000992280304200408","article-title":"Vertebral fractures in boys with Duchenne muscular dystrophy.","volume":"42","author":"Bothwell","year":"2003","journal-title":"Clin Pediatr (Phila)"},{"issue":"11","key":"noi190007r10","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.nmd.2016.08.011","article-title":"Bone health measures in glucocorticoid-treated ambulatory boys with Duchenne muscular dystrophy.","volume":"26","author":"Tian","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"noi190007r11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bone.2018.07.019","article-title":"Growth, bone health & ambulatory status of boys with DMD treated with daily vs intermittent oral glucocorticoid regimen.","volume":"116","author":"Crabtree","year":"2018","journal-title":"Bone"},{"issue":"6","key":"noi190007r12","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/jnnp-2012-303902","article-title":"Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy.","volume":"84","author":"Ricotti","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"noi190007r13","first-page":"149","article-title":"The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials.","volume":"87","author":"Ricotti","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"noi190007r14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/(ISSN)1097-0258","article-title":"British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood.","volume":"17","author":"Cole","year":"1998","journal-title":"Stat Med"},{"issue":"1","key":"noi190007r15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/adc.73.1.17","article-title":"Cross sectional stature and weight reference curves for the UK, 1990.","volume":"73","author":"Freeman","year":"1995","journal-title":"Arch Dis Child"},{"issue":"9","key":"noi190007r18","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/(ISSN)1097-4598","article-title":"A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy.","volume":"23","author":"Bonifati","year":"2000","journal-title":"Muscle Nerve"},{"issue":"20","key":"noi190007r19","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1212\/WNL.0000000000003217","article-title":"Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.","volume":"87","author":"Griggs","year":"2016","journal-title":"Neurology"},{"key":"noi190007r20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bone.2016.01.015","article-title":"Ethnic and geographic variations in the epidemiology of childhood fractures in the United Kingdom.","volume":"85","author":"Moon","year":"2016","journal-title":"Bone"},{"issue":"9","key":"noi190007r21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1590\/0004-282X20160107","article-title":"Pain characterization in Duchenne muscular dystrophy.","volume":"74","author":"Silva","year":"2016","journal-title":"Arq Neuropsiquiatr"},{"issue":"7","key":"noi190007r22","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1359\/jbmr.090202","article-title":"Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program.","volume":"24","author":"Halton","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"3","key":"noi190007r23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s002239900417","article-title":"A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: prednisone versus deflazacort.","volume":"62","author":"LoCascio","year":"1998","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"noi190007r24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/BF02405310","article-title":"Comparative study of deflazacort, a new synthetic corticosteroid, and dexamethasone on the synthesis of collagen in different rat bone cell populations and rabbit articular chondrocytes.","volume":"36","author":"Guenther","year":"1984","journal-title":"Calcif Tissue Int"},{"issue":"9","key":"noi190007r25","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/jbmr.5650070912","article-title":"Effects of deflazacort on aspects of bone formation in cultures of intact calvariae and osteoblast-enriched cells.","volume":"7","author":"Canalis","year":"1992","journal-title":"J Bone Miner Res"},{"issue":"6","key":"noi190007r26","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3346\/jkms.2001.16.6.769","article-title":"Deflazacort increases osteoclast formation in mouse bone marrow culture and the ratio of RANKL\/OPG mRNA expression in marrow stromal cells.","volume":"16","author":"Chung","year":"2001","journal-title":"J Korean Med Sci"},{"issue":"3","key":"noi190007r27","first-page":"428","article-title":"Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.","volume":"88","author":"Loftus","year":"1991","journal-title":"Pediatrics"},{"key":"noi190007r28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/rheumatology\/32.suppl_2.39","article-title":"Dose-dependent effects of deflazacort and prednisone on growth and skeletal maturation.","volume":"32","author":"Aicardi","year":"1993","journal-title":"Br J Rheumatol"},{"issue":"4","key":"noi190007r29","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s004670050308","article-title":"A controlled study of deflazacort in the treatment of idiopathic nephrotic syndrome.","volume":"11","author":"Broyer","year":"1997","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"noi190007r30","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/mus.26191","article-title":"Deflazacort versus prednisone\/prednisolone for maintaining motor function and delaying loss of ambulation: a post HOC analysis from the ACT DMD trial.","volume":"58","author":"Shieh","year":"2018","journal-title":"Muscle Nerve"},{"issue":"6","key":"noi190007r31","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1046\/j.1365-2265.2003.01790.x","article-title":"Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia.","volume":"58","author":"Wallace","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"noi190007r32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000447583","article-title":"Skeletal fragility in children with chronic disease.","volume":"86","author":"Joseph","year":"2016","journal-title":"Horm Res Paediatr"},{"key":"noi190007r33","first-page":"CD010899","article-title":"Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.","volume":"1","author":"Bell","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"11-12","key":"noi190007r34","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.nmd.2007.05.008","article-title":"Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy.","volume":"17","author":"S\u00f6derpalm","year":"2007","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"noi190007r35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1210\/er.2015-1026","article-title":"Growth and the growth hormone-insulin like growth factor 1 axis in children with chronic inflammation: current evidence, gaps in knowledge, and future directions.","volume":"37","author":"Wong","year":"2016","journal-title":"Endocr Rev"},{"issue":"5","key":"noi190007r36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1136\/archdischild-2016-311820","article-title":"Bone protective agents in children.","volume":"103","author":"Wood","year":"2018","journal-title":"Arch Dis Child"},{"key":"noi190007r16","volume-title":"The Design and Analysis of Cohort Studies","author":"Breslow","year":"1987"},{"key":"noi190007r17","volume-title":"Statistical Methods in Medical Research","author":"Armitage","year":"1994","edition":"3rd ed"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaneurology\/article-pdf\/76\/6\/701\/17656781\/jamaneurology_joseph_2019_oi_190007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T11:01:10Z","timestamp":1560164470000},"score":1,"resource":{"primary":{"URL":"http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2019.0242"}},"subtitle":["Results From the UK NorthStar Database"],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2019.0242","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6,1]]}}}